OBJECTIVE: To provide the international community with an estimate of the amount of financial resources needed to scale up malaria control to reach international goals, including allocations by country, year and intervention as well as an indication of the current funding gap. METHODS: A costing model was used to estimate the total costs of scaling up a set of widely recommended interventions, supporting services and programme strengthening activities in each of the 81 most heavily affected malaria-endemic countries. Two scenarios were evaluated, using different assumptions about the effect of interventions on the needs for diagnosis and treatment. Current health expenditures and funding for malaria control were compared to estimated needs. FINDINGS: A total of US$ 38 to 45 billion will be required from 2006 to 2015. The average cost during this period is US$ 3.8 to 4.5 billion per year. The average costs for Africa are US$ 1.7 billion and US$ 2.2 billion per year in the optimistic and pessimistic scenarios, respectively; outside Africa, the corresponding costs are US$ 2.1 billion and US$ 2.4 billion. CONCLUSION: While these estimates should not be used as a template for country-level planning, they provide an indication of the scale and scope of resources required and can help donors to collaborate towards meeting a global benchmark and targeting funding to countries in greatest need. The analysis highlights the need for much greater resources to achieve the goals and targets for malaria control set by the international community.
OBJECTIVE: To provide the international community with an estimate of the amount of financial resources needed to scale up malaria control to reach international goals, including allocations by country, year and intervention as well as an indication of the current funding gap. METHODS: A costing model was used to estimate the total costs of scaling up a set of widely recommended interventions, supporting services and programme strengthening activities in each of the 81 most heavily affected malaria-endemic countries. Two scenarios were evaluated, using different assumptions about the effect of interventions on the needs for diagnosis and treatment. Current health expenditures and funding for malaria control were compared to estimated needs. FINDINGS: A total of US$ 38 to 45 billion will be required from 2006 to 2015. The average cost during this period is US$ 3.8 to 4.5 billion per year. The average costs for Africa are US$ 1.7 billion and US$ 2.2 billion per year in the optimistic and pessimistic scenarios, respectively; outside Africa, the corresponding costs are US$ 2.1 billion and US$ 2.4 billion. CONCLUSION: While these estimates should not be used as a template for country-level planning, they provide an indication of the scale and scope of resources required and can help donors to collaborate towards meeting a global benchmark and targeting funding to countries in greatest need. The analysis highlights the need for much greater resources to achieve the goals and targets for malaria control set by the international community.
Authors: Alexander K Rowe; Samantha Y Rowe; Robert W Snow; Eline L Korenromp; Joanna Rm Armstrong Schellenberg; Claudia Stein; Bernard L Nahlen; Jennifer Bryce; Robert E Black; Richard W Steketee Journal: Int J Epidemiol Date: 2006-02-28 Impact factor: 7.196
Authors: Emelda A Okiro; David Bitira; Gladys Mbabazi; Arthur Mpimbaza; Victor A Alegana; Ambrose O Talisuna; Robert W Snow Journal: BMC Med Date: 2011-04-13 Impact factor: 8.775
Authors: Peter W Gething; Viola C Kirui; Victor A Alegana; Emelda A Okiro; Abdisalan M Noor; Robert W Snow Journal: PLoS Med Date: 2010-07-06 Impact factor: 11.069
Authors: Lesong Conteh; Edith Patouillard; Margaret Kweku; Rosa Legood; Brian Greenwood; Daniel Chandramohan Journal: PLoS One Date: 2010-08-17 Impact factor: 3.240
Authors: Yvonne Geissbühler; Khadija Kannady; Prosper Pius Chaki; Basiliana Emidi; Nicodem James Govella; Valeliana Mayagaya; Michael Kiama; Deo Mtasiwa; Hassan Mshinda; Steven William Lindsay; Marcel Tanner; Ulrike Fillinger; Marcia Caldas de Castro; Gerry Francis Killeen Journal: PLoS One Date: 2009-03-31 Impact factor: 3.240